Beyond Air (XAIR) Share-based Compensation Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 | -39.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.37% |
| Sep 30, 2025 | -33.33% |
| Jun 30, 2025 | -33.33% |
| Mar 31, 2025 | 100.94% |
| Dec 31, 2024 | 254.14% |
| Sep 30, 2024 | -95.36% |
| Jun 30, 2024 | -95.09% |
| Mar 31, 2024 | -31.29% |
| Dec 31, 2023 | 16.67% |
| Sep 30, 2023 | 822.86% |
| Jun 30, 2023 | 781.12% |
| Mar 31, 2023 | -482.89% |
| Dec 31, 2022 | -35.48% |
| Sep 30, 2022 | -39.39% |
| Jun 30, 2022 | -42.93% |
| Mar 31, 2022 | 298.57% |
| Dec 31, 2021 | -12.35% |
| Sep 30, 2021 | -2.12% |
| Jun 30, 2021 | -33.03% |
| Mar 31, 2021 | -17.83% |
| Dec 31, 2020 | 48.48% |
| Sep 30, 2020 | 27.84% |
| Jun 30, 2020 | 92.84% |
| Mar 31, 2020 | 19.22% |
| Dec 31, 2019 | -6.69% |
| Sep 30, 2019 | 9.62% |
| Jun 30, 2019 | 1,076.92% |
| Mar 31, 2019 | 484.87% |
| Dec 31, 2018 | 243.98% |
| Sep 30, 2018 | 81.08% |
| Jun 30, 2018 | -95.61% |
| Mar 31, 2018 | -92.20% |
| Dec 31, 2017 | 4,552.50% |
| Sep 30, 2017 | 447.06% |
| Jun 30, 2017 | 1,778.35% |
| Mar 31, 2017 | 898.64% |